Chemoinformaics analysis of 5,3?-dibenzoyloxy-3,6,7,4- teramethoxyflavone
Molecular Weight | 448.471 | nRot | 8 |
Heavy Atom Molecular Weight | 424.279 | nRig | 24 |
Exact Molecular Weight | 448.152 | nRing | 4 |
Solubility: LogS | -5.992 | nHRing | 1 |
Solubility: LogP | 4.293 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 4 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 3 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 22 |
No. of Oxygen atom | 7 | No. of Arom Bond | 23 |
nHA | 7 | APOL | 65.037 |
nHD | 0 | BPOL | 35.361 |
QED | 0.372 |
Synth | 2.287 |
Natural Product Likeliness | 0.477 |
NR-PPAR-gamma | 0.156 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 1 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.715 |
MDCK | 0.000044 |
BBB | 0.041 |
PPB | 0.904654 |
VDSS | 0.481 |
FU | 0.0516337 |
CYP1A2-inh | 0.314 |
CYP1A2-sub | 0.973 |
CYP2c19-inh | 0.9 |
CYP2c19-sub | 0.451 |
CYP2c9-inh | 0.922 |
CYP2c9-sub | 0.923 |
CYP2d6-inh | 0.01 |
CYP2d6-sub | 0.927 |
CYP3a4-inh | 0.756 |
CYP3a4-sub | 0.897 |
CL | 5.294 |
T12 | 0.24 |
hERG | 0.457 |
Ames | 0.401 |
ROA | 0.078 |
SkinSen | 0.699 |
Carcinogencity | 0.14 |
EI | 0.06 |
Respiratory | 0.131 |
NR-Aromatase | 0.79 |
Antiviral | No |
Prediction | 0.542394 |